Cart before the horse

“In a way, the cart came before the horse.” We can slow geographic atrophy. What we cannot do yet is show the patient in clinic that we did. That gap is where treatment fatigue starts, and it is the real subject of GA in Practice, the new iD Social roundtable with Murtaza Adam, MD, Ferhina Ali, MD and Seenu Hariprasad, MD. Who to treat, when to start, and what it takes to keep patients coming back. Watch the full discussion online at: https://www.idsocial.com/roundtables/buying-time Editorially independent content produced with support from Astellas. Dr. Adam has the following financial disclosures: Genentech, Regeneron, Abbvie, Apellis, Northgauge Healthcare Advisors, Alkeus, Neurotech, Amgen, Iveric Bio (an Astellas Company), Harrow, EyeBio, RegenxbioRegenXBio, EyePoint, Ocular Therapeutix, Kriya, 4DMT, Boxer Capital Management, Lumata Health, Sanro Health.  #GeographicAtrophy #Retina #Ophthalmology #AMD #GAinPractice #iDSocial